Literature DB >> 20538136

Comparison of procedural and in-hospital outcomes of percutaneous balloon aortic valvuloplasty in patients >80 years versus patients < or =80 years.

Creighton W Don1, Christian Witzke, Roberto J Cubeddu, Jesus Herrero-Garibi, Eugene Pomerantsev, Angel E Caldera, David McCarty, Ignacio Inglessis, Igor F Palacios.   

Abstract

Percutaneous balloon aortic valvuloplasty (PBAV) is a procedure used for palliation, bridging to surgery, and as an integral step in the procedure for percutaneous aortic valve replacement. Older patients with severe aortic stenosis are thought to have greater risk for adverse perioperative events than younger patients. The aim of this study was to evaluate the outcomes of patients aged >80 years and those aged < or =80 years who underwent PBAV to identify factors associated with adverse clinical outcomes. This was a retrospective study of 111 consecutive patients with severe symptomatic aortic stenosis who underwent retrograde PBAV at Massachusetts General Hospital from December 2004 to December 2008. Forty-nine patients (44%) were men, and the mean age for the whole group was 82 +/- 8 years. Patients were divided into 2 age groups: those aged >80 years (n = 73) and those aged < or =80 years (n = 38). Procedural outcomes, complications, and in-hospital adverse events were compared. Multivariate logistic regression was used for the adjusted analysis. Nearly 90% of patients were in New York Heart Association class III or IV. Patients aged >80 years had lower baseline ejection fractions (43.5% vs 56.1%, p <0.01) and smaller aortic valve areas (0.59 vs 0.73 cm(2), p <0.01). Although the 2 age groups had a similar percentage of aortic valve area increase (55.5% vs 45.2%, p = 0.28), those aged >80 years had smaller post-PBAV aortic valve areas (0.89 vs 1.02 cm(2), p <0.05). Overall, in-hospital mortality was 8.1%, with no significant differences between the groups. Advanced age was not an independent predictor of in-hospital death, myocardial infarction, stroke, cardiac arrest, or tamponade; however, patients aged >80 years had a significantly higher incidence of intraprocedural emergent intubation and cardiopulmonary resuscitation compared to the younger group. New York Heart Association class was the only independent predictor of worse in-hospital outcomes. In conclusion, compared to younger patients, those aged >80 years had less favorable preprocedural characteristics for PBAV but similar overall in-hospital clinical outcomes. Patients aged >80 years had significantly higher incidence of emergent intubation and cardiopulmonary resuscitation during PBAV.

Entities:  

Mesh:

Year:  2010        PMID: 20538136     DOI: 10.1016/j.amjcard.2010.01.366

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  A novel clinical prediction rule for 30-day mortality following balloon aortic valuloplasty: the CRRAC the AV score.

Authors:  Sammy Elmariah; Steven A Lubitz; Amil M Shah; Marc A Miller; Dheeraj Kaplish; Sharad Kothari; Pedro R Moreno; Annapoorna S Kini; Samin K Sharma
Journal:  Catheter Cardiovasc Interv       Date:  2011-03-16       Impact factor: 2.692

2.  Left ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplasty.

Authors:  Roberto J Cubeddu; Creighton W Don; Sofia A Horvath; Pritha P Gupta; Ignacio Cruz-Gonzalez; Christian Witzke; Ignacio Inglessis; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2013-12-04       Impact factor: 2.692

3.  Aortic balloon valvuloplasty before transcatheter valve replacement in high-risk patients with aortic stenosis. Cardiac catheterization and echocardiographic hemodynamic study.

Authors:  V Kamperidis; S Hadjimiltiades; S A Mouratoglou; A Ziakas; G Sianos; A Sarafidou; I Ventoulis; G Kazinakis; G Giannakoulas; G K Efthimiadis; G Parcharidis; H Karvounis
Journal:  Herz       Date:  2015-09-17       Impact factor: 1.443

4.  The clinical anatomy and pathology of the human arterial valves: implications for repair or replacement.

Authors:  Michael G Bateman; Alexander J Hill; Jason L Quill; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-17       Impact factor: 4.132

5.  Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes.

Authors:  Creighton Don; Pritha P Gupta; Christian Witzke; Manoj Kesarwani; Roberto J Cubeddu; Ignacio Inglessis; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2012-08-23       Impact factor: 2.692

6.  Vascular complications and bleeding after balloon aortic valvuloplasty performed with or without heparin: HEPAVALVE randomized study.

Authors:  Mariama Akodad; Jessica Labour; Erika Nogue; Delphine Delseny; Jean-Christophe Macia; Richard Gervasoni; Benoit Lattuca; Nicolas Nagot; François Roubille; Guillaume Cayla; Florence Leclercq
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-18

7.  Balloon aortic valvuloplasty as a palliative treatment in patients with severe aortic stenosis and limited life expectancy: a single center experience.

Authors:  Francesca Mantovani; Marie-Annick Clavel; Antonella Potenza; Chiara Leuzzi; Teresa Grimaldi; Luigi Vignali; Alessandro Navazio; Vincenzo Guiducci
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.